These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Clinical aspects, immunologic assessment, and genetic analysis in Taiwanese children with hemophagocytic lymphohistiocytosis. Lee WI; Chen SH; Hung IJ; Yang CP; Jaing TH; Chen CJ; Li SP; Huang JL Pediatr Infect Dis J; 2009 Jan; 28(1):30-4. PubMed ID: 19057461 [TBL] [Abstract][Full Text] [Related]
10. [Screening for cytotoxic defects with flow cytometric detection of CD107α on natural killer cells and cytotoxic lymphocyte cells]. Wang J; Liu Z; Jiang LP; An YF; Zhao XD Zhonghua Er Ke Za Zhi; 2012 May; 50(5):386-91. PubMed ID: 22883044 [TBL] [Abstract][Full Text] [Related]
14. Functional and genetic testing in adults with HLH reveals an inflammatory profile rather than a cytotoxicity defect. Carvelli J; Piperoglou C; Farnarier C; Vely F; Mazodier K; Audonnet S; Nitschke P; Bole-Feysot C; Boucekine M; Cambon A; Hamidou M; Harle JR; de Saint Basile G; Kaplanski G Blood; 2020 Jul; 136(5):542-552. PubMed ID: 32356861 [TBL] [Abstract][Full Text] [Related]
15. Hemophagocytic syndrome: primary forms and predisposing conditions. Sepulveda FE; de Saint Basile G Curr Opin Immunol; 2017 Dec; 49():20-26. PubMed ID: 28866302 [TBL] [Abstract][Full Text] [Related]
16. Familial hemophagocytic lymphohistiocytosis: a model for understanding the human machinery of cellular cytotoxicity. Sieni E; Cetica V; Mastrodicasa E; Pende D; Moretta L; Griffiths G; Aricò M Cell Mol Life Sci; 2012 Jan; 69(1):29-40. PubMed ID: 21990010 [TBL] [Abstract][Full Text] [Related]
17. The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis. Bode SF; Ammann S; Al-Herz W; Bataneant M; Dvorak CC; Gehring S; Gennery A; Gilmour KC; Gonzalez-Granado LI; Groß-Wieltsch U; Ifversen M; Lingman-Framme J; Matthes-Martin S; Mesters R; Meyts I; van Montfrans JM; Pachlopnik Schmid J; Pai SY; Soler-Palacin P; Schuermann U; Schuster V; Seidel MG; Speckmann C; Stepensky P; Sykora KW; Tesi B; Vraetz T; Waruiru C; Bryceson YT; Moshous D; Lehmberg K; Jordan MB; Ehl S; Haematologica; 2015 Jul; 100(7):978-88. PubMed ID: 26022711 [TBL] [Abstract][Full Text] [Related]
18. Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Gupta S; Weitzman S Expert Rev Clin Immunol; 2010 Jan; 6(1):137-54. PubMed ID: 20383897 [TBL] [Abstract][Full Text] [Related]
19. Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity. Wood SM; Meeths M; Chiang SC; Bechensteen AG; Boelens JJ; Heilmann C; Horiuchi H; Rosthøj S; Rutynowska O; Winiarski J; Stow JL; Nordenskjöld M; Henter JI; Ljunggren HG; Bryceson YT Blood; 2009 Nov; 114(19):4117-27. PubMed ID: 19704116 [TBL] [Abstract][Full Text] [Related]
20. Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome. Jessen B; Maul-Pavicic A; Ufheil H; Vraetz T; Enders A; Lehmberg K; Längler A; Gross-Wieltsch U; Bay A; Kaya Z; Bryceson YT; Koscielniak E; Badawy S; Davies G; Hufnagel M; Schmitt-Graeff A; Aichele P; Zur Stadt U; Schwarz K; Ehl S Blood; 2011 Oct; 118(17):4620-9. PubMed ID: 21878672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]